Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 4:21 pm Sale | 13G | Mirati Therapeutics Inc. MRTX | BAKER BROS. ADVISORS LP | 0 0.000% | -1,995,200 (Position Closed) | View |
| 2024-02-14 2:51 pm Sale | 13G | Mirati Therapeutics Inc. MRTX | ARMISTICE CAPITAL LLC | 500,000 0.710% | -2,988,000 (-85.67%) | View |
| 2024-02-14 09:13 am Sale | 13G | Mirati Therapeutics Inc. MRTX | Avoro Capital Advisors LLC | 4,886,840 7.000% | -668,715 (-12.04%) | View |
| 2024-02-14 07:12 am Sale | 13G | Mirati Therapeutics Inc. MRTX | RTW INVESTMENTS LP | 0 0.000% | -3,643,114 (Position Closed) | View |
| 2024-02-13 5:09 pm Purchase | 13G | Mirati Therapeutics Inc. MRTX | VANGUARD GROUP INC | 5,306,693 7.570% | 332,805 (+6.69%) | View |
| 2024-02-09 12:29 pm Sale | 13G | Mirati Therapeutics Inc. MRTX | MORGAN STANLEY MS | 0 0.000% | -6,079,302 (Position Closed) | View |
| 2024-02-09 12:20 pm Purchase | 13G | Mirati Therapeutics Inc. MRTX | MORGAN STANLEY MS | 6,079,302 8.700% | 6,079,302 (New Position) | View |
| 2024-02-08 10:14 am Sale | 13G | Mirati Therapeutics Inc. MRTX | WELLINGTON MANAGEMENT GROUP LLP | 0 0.000% | -3,016,335 (Position Closed) | View |
| 2024-01-31 2:08 pm Purchase | 13G | Mirati Therapeutics Inc. MRTX | BlackRock Inc. BLK | 3,866,202 5.500% | 1,109,527 (+40.25%) | View |
| 2024-01-25 4:31 pm Sale | 13D | Mirati Therapeutics Inc. MRTX | Boxer Capital LLC | 0 0.000% | -11,661,726 (Position Closed) | View |
| 2023-12-27 4:05 pm Purchase | 13G | Mirati Therapeutics Inc. MRTX | EcoR1 Capital LLC | 7,396,979 10.500% | 1,648,580 (+28.68%) | View |
| 2023-10-12 1:07 pm Unchanged | 13D | Mirati Therapeutics Inc. MRTX | Boxer Capital LLC | 11,661,726 15.900% | 0 (Unchanged) | View |
| 2023-10-02 4:08 pm Purchase | 13G | Mirati Therapeutics Inc. MRTX | EcoR1 Capital LLC | 5,748,399 8.500% | 5,748,399 (New Position) | View |
| 2023-08-16 4:28 pm Purchase | 13D | Mirati Therapeutics Inc. MRTX | Boxer Capital LLC | 11,661,726 15.900% | 1,370,879 (+13.32%) | View |
| 2023-02-14 2:35 pm Sale | 13G | Mirati Therapeutics Inc. MRTX | PERCEPTIVE ADVISORS LLC | 2,191,425 3.800% | -1,092,358 (-33.27%) | View |
| 2023-02-14 1:10 pm Purchase | 13G | Mirati Therapeutics Inc. MRTX | ARMISTICE CAPITAL LLC | 3,488,000 6.060% | 3,488,000 (New Position) | View |
| 2023-02-14 10:09 am Purchase | 13G | Mirati Therapeutics Inc. MRTX | RTW INVESTMENTS LP | 3,643,114 6.300% | 3,643,114 (New Position) | View |
| 2023-02-14 09:34 am Purchase | 13G | Mirati Therapeutics Inc. MRTX | Avoro Capital Advisors LLC | 5,555,555 9.600% | 480,555 (+9.47%) | View |
| 2023-02-09 11:27 am Purchase | 13G | Mirati Therapeutics Inc. MRTX | VANGUARD GROUP INC | 4,973,888 8.640% | 534,911 (+12.05%) | View |
| 2023-02-06 2:53 pm Sale | 13G | Mirati Therapeutics Inc. MRTX | WELLINGTON MANAGEMENT GROUP LLP | 3,016,335 5.240% | -129,297 (-4.11%) | View |